Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
03/2007
03/14/2007CN1304242C Article handling device and method
03/14/2007CN1304051C PSGL-1 regulator
03/13/2007US7191068 Proteomic analysis of biological fluids
03/13/2007US7190522 Chemical synthesis using diffraction grating-based encoded optical elements
03/13/2007US7189842 A relaxed oriented plastic substrate with reactants and labels directly attached at binding sites where the structures of the reactants are identifiable by their discrete location; the label amount is proportional to the amount of reactant; increase detection signal strength; high surface area; kinetics
03/13/2007US7189838 PRO9834 nucleic acids
03/13/2007US7189837 Cell surface molecule-induced macrophage activation
03/13/2007US7189827 Fusion of Fc domains with biologically active peptides and a process for preparing pharmaceutical agents using biologically active peptides; recombinant proteins
03/13/2007US7189825 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders; antitumor agents; immunotherapy
03/13/2007US7189824 Monoclonal antibody which recognizes an antigen on the surface of tumor vessel endothelial cells; conjugates with diagnostic, chemotherapeutic agents for diagnosis or treatment of tumors
03/13/2007US7189823 Monoclonal antibody useful in the diagnosis of proliferative disorders of the colon such as colon cancer; ILLFDYFNR is a colon cancer antigen sequence
03/13/2007US7189820 Antibody for use in the treatment, prevention and diagnosis of cancer, autoimmune, arthritic and graft vs. host diseases
03/13/2007US7189816 Antibody having a binding structure comprising specified complementarity determining region (CDR) sequences for a target tumor antigen on human gastrointestinal epithelial tumour cells; colon cancer diagnosis or immunotherapy
03/13/2007US7189813 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
03/13/2007US7189812 Comprises maternal protein (MATER) for treatment of infertility and reduced fertility; contraceptives
03/13/2007US7189810 Polypeptides, use thereof and process for producing the same
03/13/2007US7189807 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
03/13/2007US7189801 Peptides and peptidomimetics with structural similarity to human p53 that activate p53 function
03/13/2007US7189800 Forming vaccines; analyzing hemagglutinin, calibration
03/13/2007US7189752 Anticancer agents
03/13/2007US7189703 Treatment and diagnosis of alzheimer's disease
03/13/2007US7189696 Peptide antagonists of zonulin and methods for use of the same
03/13/2007US7189592 Metallization of material for detection of hydrogen and etching to form patterns
03/13/2007US7189582 Compositions and methods for detection of sirolimus
03/13/2007US7189579 Radiation transparent vessels comprising sorbent ion exchange resins and separators for soil treatment
03/13/2007US7189576 Using dye; colorimetric analysis; forming insoluble compound
03/13/2007US7189575 Method and device for determining the swelling behavior of polymer gels under pressure
03/13/2007US7189574 Measurement of nitrogen content in a gas mixture by transforming the nitrogen into a substance detectable with nondispersive infrared detection
03/13/2007US7189573 Apparatus and method for process monitoring
03/13/2007US7189571 Method for trace water analysis in cyclic siloxanes useful as precursors for low dielectric constant thin films
03/13/2007US7189565 Comprises polypeptide associated with urogenital system for detection, prevention and treatment of cancer
03/13/2007US7189554 Expression vector for use in screening antibiotics for prevention of neisseria infections
03/13/2007US7189551 Human RPS6KA6-related gene variant associated with lung cancers
03/13/2007US7189525 Human enzymes of the metalloprotease family
03/13/2007US7189524 Receptor ligands and methods of modulating receptors
03/13/2007US7189523 Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a B-cell associated protein
03/13/2007US7189522 Test device with a conjugate having marker, for determining ligand presence in liquid sample; immobilized ligand-binding mechanism for antigens, antibodies, aptamers, and/or nucleic acids; sorbent strips touching each other at test site; fluid flow migration path; high speed, accuracy
03/13/2007US7189521 Claudin polypeptides, polynucleotides, and methods of making and use thereof
03/13/2007US7189520 Compositions and methods for detecting animal byproduct in feed
03/13/2007US7189519 Identifying bound modified g-protein coupled receptors assemblies; microarrays; drug screening; colorimetric analysis
03/13/2007US7189518 Soluble CD40L(CD154) as a prognostic marker of atherosclerotic diseases
03/13/2007US7189517 Goodpasture antigen binding protein
03/13/2007US7189516 Method for characterizing autoimmune disorders
03/13/2007US7189515 Human antibodies as detection reagents
03/13/2007US7189513 Human papilloma virus immunoreactive peptides
03/13/2007US7189510 Response element compositions and assays employing same
03/13/2007US7189507 Detecting transcription products associated urogenital cancers drug screening; drug screening; antiproliferative agents
03/13/2007US7189504 Compositions and methods for detecting and quantifying COX-2 activity and 2-arachidonylglycerol metabolites
03/13/2007US7189503 Analysis system comprising structure of an ion-permeable passage connecting first AND second pools; molecular motor of processive nucleic acid translocation is not bacteriophage receptor; differentiation between hybridized nucleotide monomers before entering channel
03/13/2007US7189404 Strain selection of pneumococcal surface proteins
03/13/2007US7189403 Attenuated flavivirus strains containing a mutated M-ectodomain and their applications
03/13/2007US7189399 Chimeric gene formed of the DNA sequences that encode the antigenic determinants of four proteins of L. infantum, useful for serologic diagnosis of canine leishmaniosis and protein obtained
03/13/2007US7189398 Amino acid sequence substantially homologous to the amino acid sequence of a fragment of a pyrogenic exotoxin, capable of eliciting protective immunity against toxic shock induced by a pyrogenic exotoxin
03/13/2007US7189397 Screening fir cytotoxic end points; cancerous disease modifying antibodies
03/13/2007US7189373 Carbon monoxide removal from reformate gas
03/13/2007US7189368 Wherenin microcavity between inlet conduit and restriction conduit in each microchannel structure creates flow with low inter-channel variation
03/13/2007US7189366 Quantitative analysis; infrared analyzing; labeling animal;s with laser dyes
03/13/2007US7189364 Hydrogen sensor
03/13/2007US7189363 Sensing the concentration of a specific gas in air, water can be discharged through down draft
03/13/2007US7189359 Integrating the electromagnet of the detecting device with the electrode of the electrowetting actuated device; less complicated manufacture, improves efficiency of conventional magnetic-beads biochemical detecting
03/13/2007US7189358 Integrated analysis chambers communicated to the micropumps; and integrated analysis devices to test said fluid in said analysis chambers for an analyte.
03/13/2007US7189357 Separation of components of immunological and immunohematological samples
03/13/2007US7189354 Optically and fluidically enhanced in vitro diagnostic test chamber
03/13/2007US7189353 Use of spatiotemporal response behavior in sensor arrays to detect analytes in fluids
03/13/2007US7189341 Transition metal catalyst, an electroconductive material such as graphite; and a polymer binder blend of high molecular weight and low molecular weight acrylic (co)polymers, one having a higher glass transition temperature (Tg); catalytic inks for screen printing; use to make electrochemical sensors
03/13/2007US7189315 Ion sensor and clinical analyzer using the same
03/13/2007US7188769 Laser scanner using rotating holographic optical element
03/13/2007US7188734 Holding device, particularly for bodily fluids, comprising a separating device, and a separating device therefor
03/13/2007US7188514 Method for providing an oil change indication to an operator of an internal combustion engine
03/13/2007CA2419461C Microorganisms and assays for the identification of antibiotics
03/13/2007CA2394609C Conformational and topological protein regulation
03/13/2007CA2262531C Assessment of cervical cells
03/13/2007CA2240380C Apparatus for screening compound libraries
03/13/2007CA2208216C Non linear multivariate infrared analysis method
03/13/2007CA2167578C Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor
03/13/2007CA2160922C Hiv immunogenic complexes
03/13/2007CA2149062C Immunoassays using a carbon sol label
03/12/2007CA2561992A1 Polynucleotides and uses thereof
03/12/2007CA2559513A1 Modified colony assay
03/09/2007CA2558986A1 Method for demonstrating efficacy of a topically applied active ingredient
03/09/2007CA2556769A1 Method of homogenisation and, optionally, analysis for processing moist noble metal-containing recycling materials with an unknown noble metal content
03/08/2007WO2007028163A1 Biocompatible fluorescent imaging agents
03/08/2007WO2007028147A2 Identification of a prostatic intraepithelial neoplasia (pin)-specific gene and protein (pin-1) useful as a diagnostic treatment for prostate cancer
03/08/2007WO2007028146A2 Chemo-sensitivity assays using tumor cells exhibiting persistent phenotypic characteristics
03/08/2007WO2007028126A2 Methods and systems for identifying insulin mimetics
03/08/2007WO2007028080A1 Colorimetric detection of cyanide with a chromogenic oxazine
03/08/2007WO2007028070A2 Use of soluble flt-1 and its fragments in cardiovascular conditions
03/08/2007WO2007028037A1 Biocompatible n, n-disubstituted sulfonamide-containing fluorescent dye labels
03/08/2007WO2007028005A2 Biomarkers and methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators
03/08/2007WO2007027957A2 Reagents for the detection of protein phosphorylation in leukemia signaling pathways
03/08/2007WO2007027938A1 Novel enhanced processes for drug testing including neoplasmic tissue slices and products thereby
03/08/2007WO2007027916A2 Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
03/08/2007WO2007027867A2 Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
03/08/2007WO2007027678A1 A test sensor with a fluid chamber opening
03/08/2007WO2007027661A2 Human g protein-coupled receptor and modulators thereof for the treatment of atherosclerosis and atherosclerotic disease and for the treatment of conditions related to mcp-1 expression
03/08/2007WO2007027653A1 Cell-based luminogenic and nonluminogenic proteasome assays
03/08/2007WO2007027630A2 Genes associated with type ii diabetes mellitus
03/08/2007WO2007027614A2 Abnormal glycosylation in tamm-horsfall protein in interstitial cystitis patient
03/08/2007WO2007027561A2 Systems and methods for fractionation of protein mixtures
03/08/2007WO2007027495A1 Complex formation method and separation method